Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesThe significance and regulatory mechanisms of innate immune cells in the development of sepsisType I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.Increased antigen presentation but impaired T cells priming after upregulation of interferon-beta induced by lipopolysaccharides is mediated by upregulation of B7H1 and GITRLHelminths and their implication in sepsis - a new branch of their immunomodulatory behaviour?Both very low- and very high in vitro cytokine responses were associated with infant death in low-birth-weight children from Guinea BissauHost responses to sepsis vary in different low-lethality murine models.Increased translocation of antigens to endosomes and TLR4 mediated endosomal recruitment of TAP contribute to nicotine augmented cross-presentation.Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses.Escherichia coli-induced immune paralysis is not exacerbated during chronic filarial infection.Toll-Like Receptor 8 Is a Major Sensor of Group B Streptococcus But Not Escherichia coli in Human Primary Monocytes and Macrophages.Macrophage heterogeneity in lymphoid tissues.CD169 Macrophages Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the Immune System
P2860
Q21131160-DE50CD86-0AF5-405E-814C-85CFF6555A2BQ26866126-BB0B2A82-1851-4356-9172-BB046952E97CQ33685904-B97C4BE4-A5FC-4AA5-B1A5-6D796C07F516Q34075613-685482DC-84F4-4F93-ABBE-DC0C6BCCF7E3Q34844755-FCB2BCEA-1A6A-43D2-86CE-F47AF099F45AQ35142918-34AC9AE5-62BA-4F17-AE8F-C0BD7EA152D0Q35161494-D3AEC30C-02FF-4810-ADFA-83C5F188B7F9Q37437538-55D853C7-B2ED-4BF0-8FB7-A7996777916DQ38851623-7B62F4BE-B057-44C4-8B93-90029F79F6CBQ40593868-6DF24DA3-BC9B-4299-99D2-5E9FCC8AB22AQ41592753-EA18F87C-2A8E-4241-A658-8B3A6AFA83B4Q42372557-CA1ACC1A-A396-4216-B3D0-B5370EBBD583Q44969513-406C7E1D-36F3-4198-A912-0BEEF35C88A5Q58707686-DA704C43-DEE7-4245-9765-225ECFC9E758
P2860
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Expression of type I interfero ...... aptive immunity during sepsis.
@en
type
label
Expression of type I interfero ...... aptive immunity during sepsis.
@en
prefLabel
Expression of type I interfero ...... aptive immunity during sepsis.
@en
P2093
P2860
P50
P356
P1433
P1476
Expression of type I interfero ...... daptive immunity during sepsis
@en
P2093
Andrea Staratschek-Jox
Andreas Limmer
Beatrix Schumak
Bernhard Holzmann
Carsten Kirschning
Christian Kurts
Christoph Coch
Frank Jüngerkes
Georg Kraal
Gerrit H Gielen
P2860
P304
P356
10.1038/EMBOJ.2011.380
P407
P577
2011-10-28T00:00:00Z